Hongping Yu

机构：Fujian University of Traditional Chinese Medicine, Fujian Medical University, Guangxi University, Guangxi Medical University, First Affiliated Hospital of Xiamen University, Fujian Provincial Hospital, Tumor Hospital of Guangxi Medical University, Fuzhou University · ORCID：0000-0001-9668-5929

发表论文 61 篇 · 总被引 508 次 · h-index 13

代表论文

• Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients (2023 · Archives of Toxicology · 被引 15)
• Functional genetic variants of the disulfidptosis-related INF2 gene predict survival of hepatitis B virus-related hepatocellular carcinoma (2024 · Carcinogenesis · 被引 7)
• CK19 protein expression: the best cutoff value on the prognosis and the prognosis model of hepatocellular carcinoma (2025 · BMC Cancer · 被引 6)
• Diagnostic journey and genetic analysis of a novel homozygous CYP2U1 mutation causing autosomal recessive spastic paraplegia type 56 (SPG56) in a consanguineous family (2025 · BMC Neurology · 被引 4)
• Genetic variants of m 6 A modification genes are associated with survival of HBV ‐related hepatocellular carcinoma (2024 · Journal of Cellular and Molecular Medicine · 被引 4)
• Multi-omics integration analysis of the amino-acid metabolism-related genes identifies putatively causal variants of ACCS associated with hepatitis B virus-related hepatocellular carcinoma survival (2025 · BMC Cancer · 被引 3)